Mirati Therapeutics Current Ratio 2006-2021 | MRTX

Current and historical current ratio for Mirati Therapeutics (MRTX) from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Mirati Therapeutics current ratio for the three months ending June 30, 2021 was 7.07.
Mirati Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $1.28B $0.18B 7.07
2021-03-31 $1.30B $0.08B 16.91
2020-12-31 $1.40B $0.07B 19.64
2020-09-30 $0.60B $0.07B 8.84
2020-06-30 $0.65B $0.06B 11.34
2020-03-31 $0.71B $0.06B 12.58
2019-12-31 $0.42B $0.05B 8.68
2019-09-30 $0.47B $0.04B 13.15
2019-06-30 $0.50B $0.03B 17.57
2019-03-31 $0.31B $0.03B 12.21
2018-12-31 $0.23B $0.03B 8.67
2018-09-30 $0.25B $0.02B 11.22
2018-06-30 $0.26B $0.02B 14.54
2018-03-31 $0.15B $0.02B 9.56
2017-12-31 $0.16B $0.01B 11.42
2017-09-30 $0.08B $0.01B 5.85
2017-06-30 $0.09B $0.01B 7.86
2017-03-31 $0.11B $0.01B 9.57
2016-12-31 $0.06B $0.02B 3.97
2016-09-30 $0.08B $0.01B 5.53
2016-06-30 $0.09B $0.01B 6.75
2016-03-31 $0.11B $0.01B 10.16
2015-12-31 $0.13B $0.01B 12.80
2015-09-30 $0.14B $0.01B 14.44
2015-06-30 $0.06B $0.01B 8.58
2015-03-31 $0.07B $0.01B 13.93
2014-12-31 $0.03B $0.01B 6.05
2014-09-30 $0.04B $0.01B 7.24
2014-06-30 $0.05B $0.05B 1.10
2014-03-31 $0.06B $0.04B 1.31
2013-12-31 $0.06B $0.04B 1.66
2013-09-30 $0.02B $0.04B 0.41
2013-06-30 $0.02B $0.02B 1.34
2013-03-31 $0.03B $0.01B 5.43
2012-12-31 $0.04B $0.01B 7.37
2012-09-30 $0.02B $0.01B 4.00
2012-06-30 $0.02B $0.00B 6.67
2012-03-31 $0.03B $0.00B 9.79
2011-12-31 $0.03B $0.00B 8.14
2011-09-30 $0.04B $0.00B 9.65
2011-06-30 $0.04B $0.01B 8.48
2011-03-31 $0.01B $0.01B 1.27
2010-12-31 $0.01B $0.01B 1.91
2010-09-30 $0.01B $0.01B 2.16
2010-06-30 $0.02B $0.01B 3.07
2010-03-31 $0.01B $0.01B 2.81
2009-12-31 $0.02B $0.01B 3.10
2009-09-30 $0.02B $0.01B 3.87
2009-06-30 $0.03B $0.01B 3.75
2009-03-31 $0.03B $0.01B 4.16
2008-12-31 $0.04B $0.01B 4.62
2008-09-30 $0.05B $0.02B 2.38
2008-06-30 $0.06B $0.01B 4.39
2008-03-31 $0.06B $0.01B 5.19
2007-12-31 $0.06B $0.01B 5.59
2007-09-30 $0.07B $0.01B 6.82
2007-06-30 $0.07B $0.01B 8.91
2007-03-31 $0.07B $0.01B 9.95
2006-12-31 $0.06B $0.01B 7.41
2006-09-30 $0.07B $0.01B 8.87
2006-06-30 $0.06B $0.01B 9.17
2006-03-31 $0.05B $0.01B 6.87
2005-12-31 $0.02B $0.00B 6.36
2005-09-30 $0.03B $0.00B 8.47
2005-06-30 $0.03B $0.00B 10.04
2005-03-31 $0.03B $0.00B 10.35
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.626B $0.013B
Mirati Therapeutics, Inc. is a biopharmaceutical company. It engaged in the development of novel therapeutics for the treatment of cancer. Mirati Therapeutics, Inc., formerly known as MethylGene Inc., is based in Montreal, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71